The role of CD146 (Mel-CAM) in biology and pathology

Research output: Contribution to journalArticle

Abstract

CD146, also known as Mel-CAM, MUC18, A32 antigen, and S-Endo-1, is a membrane glycoprotein which functions as a Ca2+-independent cell adhesion molecule involved in heterophilic cell-cell interactions. Based on homology of the nucleotide sequence, CD146 is classified as a member of the immunoglobulin gene superfamily, since it contains the characteristic V-V-C2- C2-C2 immunoglobulin-like domain structure. Using immunohistochemistry with CD146-specific antibodies, CD146 expression has been demonstrated in a relatively limited spectrum of normal human tissues and malignant neoplasms. The lineage-specific expression pattern of CD146 can be useful in the differential diagnosis of certain lesions including melanomas and various types of gestational trophoblastic lesions. Although the biological role of CD146 in normal tissue and malignant turnouts remains unclear, CD146 has been suggested to play an important role in turnout progression, implantation and placentation. CD146 expression can promote turnout progression in human melanoma, possibly through enhanced interaction between melanoma cells and endothelial cells. In contrast, CD146 may act as a turnout suppressor in breast carcinoma. CD146 expression is frequently lost in breast carcinomas and overexpression of CD146 in breast carcinoma cells results in a more cohesive cell growth and the formation of smaller turnouts in nude mice. During implantation and placentation, CD146 expressed by the intermediate trophoblast in the placental site binds to its putative receptor in uterine smooth muscle cells and limits trophoblastic invasion in the myometrium. In conclusion, CD146 is a recently identified novel-cell adhesion molecule and its biological functions and role as a diagnostic marker in pathology are now being recognized. Identification of the receptor for CD146 and the development of experimental models that can account for the complex interactions between CD146-expressing cells and their microenvironment are needed to investigate further the functions of this molecule in biology and in pathological states.

Original languageEnglish (US)
Pages (from-to)4-11
Number of pages8
JournalJournal of Pathology
Volume189
Issue number1
DOIs
StatePublished - 1999

Fingerprint

Pathology
Melanoma
Placentation
Myometrium
Cell Adhesion Molecules
Breast Neoplasms
Cellular Microenvironment
Immunoglobulin Genes
Membrane Glycoproteins
Trophoblasts
Nude Mice
Cell Communication
Smooth Muscle Myocytes
Differential Diagnosis
Theoretical Models
Endothelial Cells
Immunohistochemistry
Antigens
Antibodies
Growth

Keywords

  • Adhesion molecule
  • CD146
  • Mel-CAM
  • Tumour suppressor gene

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

The role of CD146 (Mel-CAM) in biology and pathology. / Shih, Ie Ming.

In: Journal of Pathology, Vol. 189, No. 1, 1999, p. 4-11.

Research output: Contribution to journalArticle

@article{c5e5b039e333423eae2690f7a5fd35ca,
title = "The role of CD146 (Mel-CAM) in biology and pathology",
abstract = "CD146, also known as Mel-CAM, MUC18, A32 antigen, and S-Endo-1, is a membrane glycoprotein which functions as a Ca2+-independent cell adhesion molecule involved in heterophilic cell-cell interactions. Based on homology of the nucleotide sequence, CD146 is classified as a member of the immunoglobulin gene superfamily, since it contains the characteristic V-V-C2- C2-C2 immunoglobulin-like domain structure. Using immunohistochemistry with CD146-specific antibodies, CD146 expression has been demonstrated in a relatively limited spectrum of normal human tissues and malignant neoplasms. The lineage-specific expression pattern of CD146 can be useful in the differential diagnosis of certain lesions including melanomas and various types of gestational trophoblastic lesions. Although the biological role of CD146 in normal tissue and malignant turnouts remains unclear, CD146 has been suggested to play an important role in turnout progression, implantation and placentation. CD146 expression can promote turnout progression in human melanoma, possibly through enhanced interaction between melanoma cells and endothelial cells. In contrast, CD146 may act as a turnout suppressor in breast carcinoma. CD146 expression is frequently lost in breast carcinomas and overexpression of CD146 in breast carcinoma cells results in a more cohesive cell growth and the formation of smaller turnouts in nude mice. During implantation and placentation, CD146 expressed by the intermediate trophoblast in the placental site binds to its putative receptor in uterine smooth muscle cells and limits trophoblastic invasion in the myometrium. In conclusion, CD146 is a recently identified novel-cell adhesion molecule and its biological functions and role as a diagnostic marker in pathology are now being recognized. Identification of the receptor for CD146 and the development of experimental models that can account for the complex interactions between CD146-expressing cells and their microenvironment are needed to investigate further the functions of this molecule in biology and in pathological states.",
keywords = "Adhesion molecule, CD146, Mel-CAM, Tumour suppressor gene",
author = "Shih, {Ie Ming}",
year = "1999",
doi = "10.1002/(SICI)1096-9896(199909)189:1<4::AID-PATH332>3.0.CO;2-P",
language = "English (US)",
volume = "189",
pages = "4--11",
journal = "Journal of Pathology",
issn = "0022-3417",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - The role of CD146 (Mel-CAM) in biology and pathology

AU - Shih, Ie Ming

PY - 1999

Y1 - 1999

N2 - CD146, also known as Mel-CAM, MUC18, A32 antigen, and S-Endo-1, is a membrane glycoprotein which functions as a Ca2+-independent cell adhesion molecule involved in heterophilic cell-cell interactions. Based on homology of the nucleotide sequence, CD146 is classified as a member of the immunoglobulin gene superfamily, since it contains the characteristic V-V-C2- C2-C2 immunoglobulin-like domain structure. Using immunohistochemistry with CD146-specific antibodies, CD146 expression has been demonstrated in a relatively limited spectrum of normal human tissues and malignant neoplasms. The lineage-specific expression pattern of CD146 can be useful in the differential diagnosis of certain lesions including melanomas and various types of gestational trophoblastic lesions. Although the biological role of CD146 in normal tissue and malignant turnouts remains unclear, CD146 has been suggested to play an important role in turnout progression, implantation and placentation. CD146 expression can promote turnout progression in human melanoma, possibly through enhanced interaction between melanoma cells and endothelial cells. In contrast, CD146 may act as a turnout suppressor in breast carcinoma. CD146 expression is frequently lost in breast carcinomas and overexpression of CD146 in breast carcinoma cells results in a more cohesive cell growth and the formation of smaller turnouts in nude mice. During implantation and placentation, CD146 expressed by the intermediate trophoblast in the placental site binds to its putative receptor in uterine smooth muscle cells and limits trophoblastic invasion in the myometrium. In conclusion, CD146 is a recently identified novel-cell adhesion molecule and its biological functions and role as a diagnostic marker in pathology are now being recognized. Identification of the receptor for CD146 and the development of experimental models that can account for the complex interactions between CD146-expressing cells and their microenvironment are needed to investigate further the functions of this molecule in biology and in pathological states.

AB - CD146, also known as Mel-CAM, MUC18, A32 antigen, and S-Endo-1, is a membrane glycoprotein which functions as a Ca2+-independent cell adhesion molecule involved in heterophilic cell-cell interactions. Based on homology of the nucleotide sequence, CD146 is classified as a member of the immunoglobulin gene superfamily, since it contains the characteristic V-V-C2- C2-C2 immunoglobulin-like domain structure. Using immunohistochemistry with CD146-specific antibodies, CD146 expression has been demonstrated in a relatively limited spectrum of normal human tissues and malignant neoplasms. The lineage-specific expression pattern of CD146 can be useful in the differential diagnosis of certain lesions including melanomas and various types of gestational trophoblastic lesions. Although the biological role of CD146 in normal tissue and malignant turnouts remains unclear, CD146 has been suggested to play an important role in turnout progression, implantation and placentation. CD146 expression can promote turnout progression in human melanoma, possibly through enhanced interaction between melanoma cells and endothelial cells. In contrast, CD146 may act as a turnout suppressor in breast carcinoma. CD146 expression is frequently lost in breast carcinomas and overexpression of CD146 in breast carcinoma cells results in a more cohesive cell growth and the formation of smaller turnouts in nude mice. During implantation and placentation, CD146 expressed by the intermediate trophoblast in the placental site binds to its putative receptor in uterine smooth muscle cells and limits trophoblastic invasion in the myometrium. In conclusion, CD146 is a recently identified novel-cell adhesion molecule and its biological functions and role as a diagnostic marker in pathology are now being recognized. Identification of the receptor for CD146 and the development of experimental models that can account for the complex interactions between CD146-expressing cells and their microenvironment are needed to investigate further the functions of this molecule in biology and in pathological states.

KW - Adhesion molecule

KW - CD146

KW - Mel-CAM

KW - Tumour suppressor gene

UR - http://www.scopus.com/inward/record.url?scp=0032817282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032817282&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1096-9896(199909)189:1<4::AID-PATH332>3.0.CO;2-P

DO - 10.1002/(SICI)1096-9896(199909)189:1<4::AID-PATH332>3.0.CO;2-P

M3 - Article

VL - 189

SP - 4

EP - 11

JO - Journal of Pathology

JF - Journal of Pathology

SN - 0022-3417

IS - 1

ER -